Search research articles
Contact Us
Filters
Showing results (371-380 of 418) with videos related to
Page
of 42
Sort By:
Cancer Cell
|
December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
Kensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Cell Reports
|
November 16, 2017
Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines
Bradley Garman, Ioannis N Anastopoulos, Clemens Krepler, et al.
Nature Medicine
|
June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
Miguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Cancer Discovery
|
February 6, 2023
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha
Avinash Sahu, Xiaoman Wang, Phillip Munson, et al.
Nature Genetics
|
February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin, Amit J Sabnis, Elton Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Ryan B Corcoran, Khanh T Do, Jeong E Kim, et al.
Nature Communications
|
June 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance
Samuel J Wright, Izabella Zamora, Milan Parikh, et al.
Oncoimmunology
|
May 4, 2016
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
Zachary A Cooper, Alexandre Reuben, Christine N Spencer, et al.
Nature Communications
|
October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy
Xue Bai, Jiani Hu, Allison Betof Warner, et al.
Page
of 42
Search research articles
Search
Showing results (371-380 of 418) with videos related to
Sort By:
Page
of 42
Cancer Cell
|
December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
Kensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Cell Reports
|
November 16, 2017
Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines
Bradley Garman, Ioannis N Anastopoulos, Clemens Krepler, et al.
Nature Medicine
|
June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
Miguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Cancer Discovery
|
February 6, 2023
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha
Avinash Sahu, Xiaoman Wang, Phillip Munson, et al.
Nature Genetics
|
February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin, Amit J Sabnis, Elton Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Ryan B Corcoran, Khanh T Do, Jeong E Kim, et al.
Nature Communications
|
June 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance
Samuel J Wright, Izabella Zamora, Milan Parikh, et al.
Oncoimmunology
|
May 4, 2016
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
Zachary A Cooper, Alexandre Reuben, Christine N Spencer, et al.
Nature Communications
|
October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy
Xue Bai, Jiani Hu, Allison Betof Warner, et al.
Page
of 42